Michael Petusky
Stock Analyst at Barrington Research
(3.59)
# 938
Out of 4,435 analysts
102
Total ratings
51.4%
Success rate
3.97%
Average return
Main Sectors:
14 Stocks
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| SRDX Surmodics | Downgrades: Market Perform | n/a | $42.06 | - | 6 | May 30, 2024 | |
| VRME VerifyMe | Maintains: Outperform | $2 → $1.7 | $1.42 | +19.72% | 6 | May 24, 2024 | |
| HAE Haemonetics | Maintains: Outperform | $105 → $107 | $84.08 | +27.26% | 14 | May 10, 2024 | |
| ANIK Anika Therapeutics | Maintains: Outperform | $37 | $25.65 | +44.25% | 8 | May 9, 2024 | |
| USPH U.S. Physical Therapy | Maintains: Outperform | $122 | $102.57 | +18.94% | 11 | May 9, 2024 | |
| HSIC Henry Schein | Maintains: Outperform | $90 → $92 | $69.34 | +32.68% | 7 | May 8, 2024 | |
| LMAT LeMaitre Vascular | Maintains: Outperform | $69 → $79 | $78.88 | +0.15% | 5 | May 3, 2024 | |
| XRAY DENTSPLY SIRONA | Maintains: Outperform | $41 → $38 | $28.01 | +35.67% | 11 | May 3, 2024 | |
| MMSI Merit Medical Systems | Maintains: Outperform | $98 → $100 | $81.15 | +23.23% | 10 | May 1, 2024 | |
| OPCH Option Care Health | Maintains: Outperform | $38 | $29.82 | +27.43% | 7 | Apr 24, 2024 | |
| OPK OPKO Health | Maintains: Outperform | $1.5 | $1.37 | +9.49% | 4 | Apr 1, 2024 | |
| MODV ModivCare | Downgrades: Market Perform | n/a | $27.32 | - | 7 | Feb 26, 2024 | |
| LFCR Lifecore Biomedical | Maintains: Outperform | $11 → $10 | $5.84 | +71.23% | 5 | Sep 1, 2023 | |
| ATIP ATI Physical Therapy | Downgrades: Market Perform | n/a | $4.76 | - | 1 | Jul 27, 2021 |
Surmodics
May 30, 2024
Downgrades: Market Perform
Price Target: n/a
Current: $42.06
Upside: -
VerifyMe
May 24, 2024
Maintains: Outperform
Price Target: $2 → $1.7
Current: $1.42
Upside: +19.72%
Haemonetics
May 10, 2024
Maintains: Outperform
Price Target: $105 → $107
Current: $84.08
Upside: +27.26%
Anika Therapeutics
May 9, 2024
Maintains: Outperform
Price Target: $37
Current: $25.65
Upside: +44.25%
U.S. Physical Therapy
May 9, 2024
Maintains: Outperform
Price Target: $122
Current: $102.57
Upside: +18.94%
Henry Schein
May 8, 2024
Maintains: Outperform
Price Target: $90 → $92
Current: $69.34
Upside: +32.68%
LeMaitre Vascular
May 3, 2024
Maintains: Outperform
Price Target: $69 → $79
Current: $78.88
Upside: +0.15%
DENTSPLY SIRONA
May 3, 2024
Maintains: Outperform
Price Target: $41 → $38
Current: $28.01
Upside: +35.67%
Merit Medical Systems
May 1, 2024
Maintains: Outperform
Price Target: $98 → $100
Current: $81.15
Upside: +23.23%
Option Care Health
Apr 24, 2024
Maintains: Outperform
Price Target: $38
Current: $29.82
Upside: +27.43%
OPKO Health
Apr 1, 2024
Maintains: Outperform
Price Target: $1.5
Current: $1.37
Upside: +9.49%
ModivCare
Feb 26, 2024
Downgrades: Market Perform
Price Target: n/a
Current: $27.32
Upside: -
Lifecore Biomedical
Sep 1, 2023
Maintains: Outperform
Price Target: $11 → $10
Current: $5.84
Upside: +71.23%
ATI Physical Therapy
Jul 27, 2021
Downgrades: Market Perform
Price Target: n/a
Current: $4.76
Upside: -